Trial | NCT01709955  Report issue

Title

The Effects of Glucomannan on Weight Loss

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    glucomannan ...

  • Study Participants

    43
The purpose of this study is to determine if the herb, Glucomannan, is an effective non-pharmacological appetite suppressant for overweight or Class I obese patients. The study design will not include any other lifestyle changes which enhance weight loss in order to completely isolate the effects of Glucomannan as a non-pharmacological appetite suppressant.
Study Started
Feb 28
2011
Primary Completion
Jul 31
2011
Study Completion
Jul 31
2011
Last Update
Oct 18
2012
Estimate

Dietary Supplement Glucomannan

750 MG of Glucomannan in capsule form

Other Placebo

750 mg of Cellulose powder in a capsule form

Gucomannan Experimental

Placebo pill Placebo Comparator

Criteria 

Inclusion Criteria:Subjects will be recruited based upon the category of them wanting to lose 50 pounds.

Subjects must be able to swallow the capsule whole with water.

Exclusion Criteria:

Self-reported use of prescription medication other than hormonal birth control (such as medication for diabetes, hypertension hypothyroidism, heart disease, cancer, etc.)
Pregnancy
Age younger than 21 or older than 60 years of age.
Screening for hypertension during the first laboratory visit that reveals a systole greater than 120 and a diastole greater than 90.
BMI calculations based upon height and weight measurements at the first laboratory visit that reveal a BMI less than 25 or greater than 35.
Self-reported iron-deficiency anemia, osteoporosis, and hypoglycemia.
No Results Posted